Accelerating the Commercialization of Sustainable Compounds by Embedding Thin Air’s Funding Catalyst Team

Overview

‍Revo Biochem is pioneering Canada's next-generation biochemical supply chain by engineering yeast through advanced fermentation to produce high-value, biosynthesized compounds at industrial scale. Targeting agriculture, food, and materials, they deliver faster, cleaner, and more sustainable alternatives that slash environmental impact, strengthen local industries, and unlock radically efficient systems for a healthier planet. As a deep-tech leader building the biorefineries of tomorrow right here in Canada, they are driving massive change - yet, like many life sciences innovators, they navigate a capital-intensive path to full commercialization.

Challenge

In the life sciences sector, the timeline to commercialization is long, and the burn rate is high. Revo Biochem needed a clear pathway to capital that wouldn't dilute their equity early on. The founders knew they wanted to secure non-dilutive capital but faced a "complexity barrier." They understood they needed to stack various grants, tax credits (like SR&ED), and other non-dilutive funding, but the landscape was challenging and cluttered. They also realized attempting to navigate the specific stacking rules of different funding bodies threatened to pull their focus away from the critical work of building their business and developing their technology.

Solution

Revo Biochem signed on for the Funding Catalyst Bundled Monthly Retainer to operationalize their non-dilutive funding strategy. The funding strategists at Thin Air didn't just advise, they embedded themselves into Revo Biochem’s team.

• Infrastructure Build: The funding strategists built Revo’s funding data room from scratch, ensuring they were "audit-ready" for any opportunity.
• Strategic Stacking: The FC team mapped a coordinated strategy for eligible grants and tax credits, handling the complex logic of how to "stack" funding without violating compliance rules.
• Ecosystem Ambassadors: Beyond the paperwork, Thin Air’s funding strategists acted as ambassadors to the life sciences community, using their relationships to open doors and broker conversations for the Revo founders.

Get in touch to learn about how we can help!

Outcome

The partnership with the Funding Catalyst team resulted in understanding and access into the non-dilutive funding landscape, allowing the Revo founders to remain resolute on building their business.

• Operational Clarity: The FC team managed the end-to-end execution of grant submissions and SR&ED claims, effectively becoming a fractional department of the company.
• Accelerated Growth: The capital and relationships secured through this partnership helped "catapult" their growth over the last year.
• Network Effects: The value extended beyond the cash; the endorsements and introductions provided by the FC team strengthened Revo’s standing in the broader investment and life sciences ecosystem.

Client Testimonial

"I think it's an imperative. I would absolutely in a heartbeat recommend the Funding Catalyst team to be a part of any new venture's arsenal. The value is greater than the sum of the parts. We've gotten more than just non-dilutive funding... we've now got relationships and clarity into the non-dilutive funding landscape and that's really helped us kind of catapult our growth." — Vikram Dhaliwal, Co-Founder & COO, Revo Biochem

Hear more from Vikram Dhaliwal about Revo’s engagement with Thin Air’s Funding Catalyst team in these Client Video Testimonials. 

Get in touch today!